Franklin Biotechnology Discv C(acc)USD

Performance History31/10/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv C(acc)USD
Fund101.547.939.8-28.017.7
+/-Cat6.53.9-3.81.0-6.1
+/-Idx-5.63.5-4.4-5.5-3.2
 
Key Stats
NAV
16/11/2017
 USD 35.97
Day Change -0.02%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0260873095
Fund Size (Mil)
31/10/2017
 USD 2355.43
Share Class Size (Mil)
31/10/2017
 USD 20.07
Max Initial Charge -
Ongoing Charge
27/01/2017
  2.41%
Investment Objective: Franklin Biotechnology Discv C(acc)USD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns16/11/2017
YTD15.70
3 Years Annualised8.98
5 Years Annualised27.98
10 Years Annualised20.86
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
01/09/2006
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv C(acc)USD31/10/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks91.570.0091.57
Bonds0.000.000.00
Cash7.670.007.67
Other0.760.000.76
Top 5 Regions%
United States97.27
United Kingdom0.77
Eurozone0.57
Canada0.45
Europe - ex Euro0.38
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare6.99
Alexion Pharmaceuticals IncHealthcareHealthcare6.90
Biogen IncHealthcareHealthcare4.87
Incyte CorpHealthcareHealthcare4.85
Illumina IncHealthcareHealthcare4.35
Franklin Biotechnology Discv C(acc)USD